| 2026-02-03 | +29.1% | earnings | Seeking Alpha | DaVita climbs as Q4 beat outshines Berkshire Hathaway insider sale |
| 2026-02-03 | +29.1% | news | Seeking Alpha | DaVita: Some Success Is Possible, But Volatility Is Still Heavy |
| 2026-02-03 | +29.1% | earnings | Seeking Alpha | DaVita outlines 33% EPS growth target for 2026 as IKC turns profitable and strategic investments accelerate |
| 2026-02-03 | +29.1% | earnings | Seeking Alpha | DaVita Inc. (DVA) Q4 2025 Earnings Call Transcript |
| 2026-02-03 | +29.1% | news | Yahoo Finance | Why Is DaVita (DVA) Stock Rocketing Higher Today - Yahoo Finance |
| 2026-02-03 | +29.1% | earnings | Yahoo Finance | DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand - Yahoo Finance |
| 2026-02-03 | +29.1% | news | Finviz | What Sent DaVita Stock Soaring On Tuesday? - Finviz |
| 2026-02-03 | +29.1% | earnings | Zacks Investment Research | DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand - Zacks Investment Research |
| 2026-02-03 | +29.1% | analyst | MarketWatch | DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2026-02-03 | +29.1% | news | MSN | Why did DaVita stock jump 15% after hours today? - MSN |
| 2026-02-03 | +29.1% | earnings | Barron's | This Berkshire Hathaway Holding Is Up 17%. Earnings Breeze Past Estimates. - Barron's |
| 2026-02-03 | +29.1% | news | Seeking Alpha | DaVita: Some Success Is Possible, But Volatility Is Still Heavy (NYSE:DVA) - Seeking Alpha |
| 2026-02-03 | +29.1% | earnings | Seeking Alpha | DaVita climbs as Q4 beat outshines Berkshire Hathaway insider sale - Seeking Alpha |
| 2026-02-03 | +29.1% | earnings | StocksToTrade | DaVita Stock Soars as Q4 Earnings and Strategy Surpass Expectations - StocksToTrade |
| 2026-02-03 | +29.1% | earnings | StocksToTrade | DaVita Stock Surges as Q4 Earnings Exceed Expectations - StocksToTrade |
| 2022-10-28 | -26.2% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2026-02-02 | +23.6% | earnings | Seeking Alpha | DaVita jumps on quarterly beats, 2026 guidance |
| 2026-02-02 | +23.6% | earnings | Seeking Alpha | DaVita Non-GAAP EPS of $3.40 beats by $0.21, revenue of $3.62B beats by $110M |
| 2026-02-02 | +23.6% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2026-02-02 | +23.6% | news | PR Newswire | DaVita Inc. 4th Quarter 2025 Results - PR Newswire |
| 2026-02-02 | +23.6% | earnings | ChartMill | DaVita Inc (NYSE:DVA) Stock Surges 15% After Q4 2025 Earnings Beat - ChartMill |
| 2026-02-02 | +23.6% | earnings | Finviz | DaVita (NYSE:DVA) Beats Expectations in Strong Q4 CY2025, Stock Soars - Finviz |
| 2026-02-02 | +23.6% | news | Stocktwits | Why Did DaVita Stock Jump 15% After Hours Today? - Stocktwits |
| 2026-02-02 | +23.6% | expansion | Stock Titan | DaVita backs home kidney care in new Elara Caring partnership - Stock Titan |
| 2023-05-08 | +14.3% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2026-02-06 | -10.2% | news | simplywall.st | Even With A 30% Surge, Cautious Investors Are Not Rewarding DaVita Inc.'s (NYSE:DVA) Performance Completely - simplywall.st |
| 2024-10-29 | -9.9% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2021-08-03 | +9.9% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2025-08-06 | -9.8% | earnings | Seeking Alpha | DaVita reiterates $2.01B–$2.16B adjusted operating income guidance for 2025 as cost controls offset volume headwinds |
| 2025-08-06 | -9.8% | earnings | Seeking Alpha | DaVita Inc. (DVA) Q2 2025 Earnings Call Transcript |
| 2025-08-06 | -9.8% | earnings | Yahoo Finance | DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands - Yahoo Finance |
| 2025-08-06 | -9.8% | news | StockStory | Why DaVita (DVA) Stock Is Nosediving - StockStory |
| 2025-02-13 | -9.5% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2026-02-11 | +9.2% | news | FinancialContent | The Dialysis Renaissance: How DaVita (DVA) Conquered the GLP-1 Fear and Defined Healthcare Resilience in 2026 - FinancialContent |
| 2025-08-05 | -8.6% | earnings | Seeking Alpha | DaVita Non-GAAP EPS of $2.95 beats by $0.20, revenue of $3.38B beats by $20M |
| 2025-08-05 | -8.6% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2024-02-13 | +8.5% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2021-10-28 | -8.1% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2023-08-03 | +7.4% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2025-10-29 | -7.3% | earnings | Seeking Alpha | DaVita narrows 2025 guidance ranges while advancing technology and clinical innovation |
| 2025-10-29 | -7.3% | earnings | Seeking Alpha | DaVita Inc. (DVA) Q3 2025 Earnings Call Transcript |
| 2025-10-29 | -7.3% | earnings | Seeking Alpha | DaVita Non-GAAP EPS of $2.51 misses by $0.66, revenue of $3.42B misses by $10M |
| 2025-10-29 | -7.3% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2025-10-29 | -7.3% | news | PR Newswire | DaVita Inc. 3rd Quarter 2025 Results - PR Newswire |
| 2023-11-07 | +7.0% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2026-04-14 | -6.6% | news | MarketWatch | DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch |
| 2025-04-14 | -6.6% | legal | SEC EDGAR | DVA 8-K: 8.01 (SEC Filing) |
| 2026-04-01 | -6.1% | earnings | Seeking Alpha | Healthcare among laggards in Q1; MRNA and DVA lead gainers while HUM drags |
| 2026-04-01 | -6.1% | news | Yahoo Finance | Here's Why DaVita HealthCare (DVA) is a Strong Value Stock - Yahoo Finance |
| 2026-04-01 | -6.1% | news | MarketWatch | DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch |
| 2024-05-02 | -6.0% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2025-10-30 | -5.2% | earnings | Yahoo Finance | DaVita Stock Down Post Q3 Earnings Miss Estimates, Revenues Up Y/Y - Yahoo Finance |
| 2026-01-13 | -5.0% | news | Yahoo Finance | DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance |
| 2026-01-13 | -5.0% | news | Investing.com | Davita stock hits 52-week low at $108.37 - Investing.com |
| 2026-01-13 | -5.0% | news | MarketWatch | DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch |
| 2024-09-13 | +4.1% | legal | SEC EDGAR | DVA 8-K: 5.02 and (SEC Filing) |
| 2025-12-18 | -4.1% | news | Yahoo Finance | Here's Why You Should Hold DaVita Stock in Your Portfolio for Now - Yahoo Finance |
| 2021-12-17 | +3.9% | legal | SEC EDGAR | DVA 8-K: 8.01 (SEC Filing) |
| 2025-10-08 | -3.9% | news | Yahoo Finance | DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance |
| 2025-10-08 | -3.9% | earnings | StockStory | Outpatient & Specialty Care Stocks Q2 Highlights: DaVita (NYSE:DVA) - StockStory |
| 2025-05-12 | -3.8% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2022-08-01 | +3.7% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2025-09-10 | -3.7% | news | Yahoo Finance | Why DaVita (DVA) Stock Is Falling Today - Yahoo Finance |
| 2026-03-25 | +3.5% | analyst | MarketWatch | DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2026-01-30 | +3.5% | earnings | Seeking Alpha | DaVita Q4 2025 Earnings Preview |
| 2021-09-09 | -3.5% | legal | SEC EDGAR | DVA 8-K: 5.02 (SEC Filing) |
| 2025-10-03 | -3.4% | news | Yahoo Finance | DaVita HealthCare (DVA) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance |
| 2026-03-30 | -3.0% | news | Yahoo Finance | Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market - Yahoo Finance |
| 2026-01-09 | -3.0% | news | Finimize | DaVita’s Stock Looks Cheap, But The Risks Are Real - Finimize |
| 2026-03-26 | +3.0% | news | Seeking Alpha | Top Quant rated undervalued large-cap stocks with high-growth grades |
| 2026-03-26 | +3.0% | analyst | MarketWatch | DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2022-05-05 | -2.9% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2025-11-10 | -2.9% | analyst | Yahoo Finance | DaVita Stock: Analyst Estimates & Ratings - Yahoo Finance |
| 2025-11-10 | -2.9% | news | DirectorsTalk Interviews | DaVita Inc. (DVA) Stock Analysis: A Robust Healthcare Play With A 16.82% Upside Potential - DirectorsTalk Interviews |
| 2022-04-08 | +2.9% | legal | SEC EDGAR | DVA 8-K: 5.02 (SEC Filing) |
| 2024-08-09 | +2.9% | legal | SEC EDGAR | DVA 8-K: 8.01 and (SEC Filing) |
| 2021-04-29 | +2.9% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2026-01-06 | -2.8% | news | Investing.com | DaVita HealthCare Partners stock hits 52-week low at $112.53 - Investing.com |
| 2026-04-22 | +2.8% | news | Zacks | DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider |
| 2026-04-22 | +2.8% | earnings | Barchart | What to Expect From DaVita's Next Quarterly Earnings Report |
| 2026-04-22 | +2.8% | news | MarketWatch | DaVita Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch |
| 2025-09-15 | -2.7% | legal | Seeking Alpha | Short bets on S&P 500 Healthcare sector eases in August; MRNA stays most shorted stock |
| 2025-10-28 | -2.6% | earnings | Seeking Alpha | DaVita Q3 2025 Earnings Preview |
| 2025-10-28 | -2.6% | earnings | Yahoo Finance | Truist Lowers PT on DaVita Inc. (DVA), Keeps a Hold Rating - Yahoo Finance |
| 2026-04-13 | -2.6% | earnings | Simply Wall St. | Assessing DaVita (DVA) Valuation After Earnings Beat Buyback Debate And EPS Guidance Questions |
| 2026-04-13 | -2.6% | news | MarketWatch | DaVita Inc. stock rises Monday, still underperforms market - MarketWatch |
| 2022-02-10 | +2.6% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2025-08-27 | -2.5% | news | Yahoo Finance | DaVita Inc. (DVA): A Bull Case Theory - Yahoo Finance |
| 2025-11-17 | -2.3% | news | Seeking Alpha | DaVita Inc. (DVA) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript |
| 2026-04-06 | +2.3% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is DaVita (DVA) Stock Good for Short Term | Price at $148.62, Up 2.09% - Most Watched Stocks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-03-20 | +2.3% | analyst | Yahoo Finance | DaVita Stock: Is DVA Outperforming the Health Care Sector? - Yahoo Finance |
| 2026-02-18 | -2.3% | executive | Yahoo Finance | Berkshire’s New CEO Just Offloaded DaVita Stocks: Should You Sell Yours Too? - Yahoo Finance |
| 2025-11-12 | +2.2% | news | Yahoo Finance | Jim Cramer Discusses DaVita’s (DVA) Share Price Movement - Yahoo Finance |
| 2025-09-13 | -2.2% | news | Yahoo Finance | Jim Cramer Highlights DaVita’s Massive Buybacks Yet Stays Cautious - Yahoo Finance |
| 2026-04-20 | +2.2% | news | PR Newswire | DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call |
| 2026-04-20 | +2.2% | news | DirectorsTalk Interviews | DaVita Inc. (DVA) Stock Analysis: Navigating Growth With A 64.85% Return On Equity - DirectorsTalk Interviews |
| 2026-04-20 | +2.2% | news | Cổng thông tin điện tử tỉnh Tây Ninh | DaVita (DVA) Stock: Support and Resistance Zones (Touches High) 2026-04-20 - Retail Picks - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-20 | +2.2% | news | AD HOC NEWS | DaVita Inc stock (US23804L1035): Why Google Discover changes matter more now - AD HOC NEWS |
| 2026-03-06 | +2.2% | news | Yahoo Finance | Here's Why You Should Add DaVita Stock to Your Portfolio for Now - Yahoo Finance |
| 2026-03-06 | +2.2% | news | TradingView | Here's Why You Should Add DaVita Stock to Your Portfolio for Now - TradingView |
| 2026-03-06 | +2.2% | news | Finviz | Here's Why You Should Add DaVita Stock to Your Portfolio for Now - Finviz |
| 2025-09-22 | +2.1% | news | Yahoo Finance | Should Value Investors Buy DaVita (DVA) Stock? - Yahoo Finance |
| 2025-12-03 | -2.0% | news | Seeking Alpha | DaVita: More Volatile But Better Upside Than Fresenius |
| 2025-12-03 | -2.0% | news | Seeking Alpha | DaVita - More Volatile But Better Upside Than Fresenius (NYSE:DVA) - Seeking Alpha |
| 2024-08-08 | +2.0% | legal | SEC EDGAR | DVA 8-K: 8.01 and (SEC Filing) |
| 2026-03-23 | +1.9% | news | Yahoo Finance | DaVita HealthCare (DVA) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance |
| 2026-03-23 | +1.9% | analyst | MarketWatch | DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2021-05-21 | -1.9% | legal | SEC EDGAR | DVA 8-K: 5.02 (SEC Filing) |
| 2026-04-15 | -1.9% | news | Zacks | DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know |
| 2026-04-15 | -1.9% | news | Yahoo Finance | DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance |
| 2026-04-15 | -1.9% | news | MarketWatch | DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch |
| 2026-01-27 | -1.9% | news | Yahoo Finance | DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance |
| 2026-03-16 | -1.8% | analyst | TIKR.com | DaVita Stock Sits at $151 With Analysts Pointing to a $190 High Target - TIKR.com |
| 2026-03-02 | -1.8% | news | Seeking Alpha | DaVita Inc. (DVA) Presents at TD Cowen 46th Annual Health Care Conference Transcript |
| 2024-04-10 | -1.7% | legal | SEC EDGAR | DVA 8-K: 5.02 (SEC Filing) |
| 2026-04-21 | +1.7% | earnings | StockStory | Outpatient & Specialty Care Stocks Q4 Earnings Review: DaVita (NYSE:DVA) Shines |
| 2026-04-21 | +1.7% | earnings | MarketBeat | Sumitomo Mitsui Trust Group Inc. Has $203,000 Position in DaVita Inc. $DVA - MarketBeat |
| 2024-05-01 | +1.7% | legal | SEC EDGAR | DVA 8-K: 1.01 and (SEC Filing) |
| 2026-03-04 | -1.7% | news | Finviz | Jim Cramer on DaVita: "Haven't Seen That Stock Do That Well In This Long" - Finviz |
| 2026-03-04 | -1.7% | news | Insider Monkey | Jim Cramer on DaVita: “Haven’t Seen That Stock Do That Well In This Long” - Insider Monkey |
| 2025-10-12 | -1.6% | analyst | Quiver Quantitative | DaVita Inc. Stock (DVA) Opinions on Analyst Downgrade - Quiver Quantitative |
| 2026-03-17 | +1.5% | earnings | Yahoo Finance | DaVita HealthCare (DVA) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance |
| 2026-02-05 | -1.5% | news | Yahoo Finance | Should Value Investors Buy DaVita (DVA) Stock? - Yahoo Finance |
| 2025-12-22 | -1.5% | earnings | Yahoo Finance | DaVita HealthCare (DVA) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance |
| 2025-10-02 | -1.4% | news | Yahoo Finance | Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term - Yahoo Finance |
| 2025-08-20 | +1.3% | news | Seeking Alpha | DaVita: Aggressive Buybacks Despite Rising Cost Of Debt |
| 2025-08-20 | +1.3% | legal | SEC EDGAR | DVA 8-K: 8.01 (SEC Filing) |
| 2026-02-09 | -1.3% | news | Yahoo Finance | DaVita Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance |
| 2026-02-09 | -1.3% | analyst | TIKR.com | DaVita Dipped 6% After Big Run-Up: Why Analysts See a Path to $210 in 2026 - TIKR.com |
| 2024-08-06 | -1.3% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2026-01-19 | +1.3% | news | Zacks Investment Research | Here's Why You Should Hold DaVita Stock in Your Portfolio for Now - Zacks Investment Research |
| 2023-07-13 | -1.2% | legal | SEC EDGAR | DVA 8-K: 5.02 (SEC Filing) |
| 2023-03-21 | -1.2% | legal | SEC EDGAR | DVA 8-K: 5.02 (SEC Filing) |
| 2023-07-25 | -1.2% | legal | SEC EDGAR | DVA 8-K: 5.02 (SEC Filing) |
| 2025-11-25 | -1.1% | legal | SEC EDGAR | DVA 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-11-21 | +1.1% | analyst | TIKR.com | DaVita Stock Prediction: Where Analysts See the Stock Going by 2027 - TIKR.com |
| 2023-05-01 | -1.0% | legal | SEC EDGAR | DVA 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-08-21 | +1.0% | earnings | Seeking Alpha | DaVita: Contraction Phase With Incremental Earnings Hurdle (Rating Downgrade) |
| 2024-09-05 | +1.0% | legal | SEC EDGAR | DVA 8-K: 5.03, 8.01 (SEC Filing) |
| 2025-12-12 | +1.0% | legal | Seeking Alpha | Short bets on S&P 500 Healthcare sector rises to 2.12% in November; MRNA stays most shorted stock |
| 2026-04-16 | +0.9% | news | StockStory | 1 Momentum Stock on Our Buy List and 2 We Turn Down |
| 2026-04-16 | +0.9% | analyst | MarketWatch | DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2024-05-13 | -0.8% | legal | SEC EDGAR | DVA 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-05-20 | -0.8% | legal | SEC EDGAR | DVA 8-K: 8.01 and (SEC Filing) |
| 2024-08-14 | +0.8% | legal | SEC EDGAR | DVA 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-03-27 | -0.8% | news | qz.com | Should Value Investors Buy DaVita (DVA) Stock? - qz.com |
| 2026-04-23 | -0.8% | news | Insider Monkey | What’s So Good About DaVita (DVA) That Warren Buffett Remains Bullish On It Since 15 Years? |
| 2026-04-23 | -0.8% | news | Yahoo Finance | What’s So Good About DaVita (DVA) That Warren Buffett Remains Bullish On It Since 15 Years? - Yahoo Finance |
| 2026-04-23 | -0.8% | analyst | MarketWatch | DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2026-03-05 | -0.7% | news | Yahoo Finance | Is DaVita Inc. (DVA) A Good Stock To Buy? - Yahoo Finance |
| 2025-10-13 | +0.7% | legal | Seeking Alpha | Short bets on S&P 500 Healthcare sector rises marginally to 1.91% in September; MRNA remains most shorted stock |
| 2026-04-02 | -0.7% | news | Yahoo Finance | DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts - Yahoo Finance |
| 2026-04-02 | -0.7% | news | MarketWatch | DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch |
| 2026-03-03 | +0.7% | news | TIKR.com | DaVita Stock Analysis: A $243 per Share Valuation Model Target - TIKR.com |
| 2023-02-22 | -0.7% | legal | SEC EDGAR | DVA 8-K: 2.02 and (SEC Filing) |
| 2022-09-13 | -0.6% | legal | SEC EDGAR | DVA 8-K: 5.02 (SEC Filing) |
| 2025-08-15 | -0.6% | legal | Seeking Alpha | Short bets on S&P 500 Healthcare sector ease in July; Moderna remains most heavily shorted stock |
| 2026-04-09 | +0.6% | news | Zacks | DaVita HealthCare (DVA) Outpaces Stock Market Gains: What You Should Know |
| 2026-04-09 | +0.6% | news | GlobeNewswire | eHealth Exchange Demonstrates Real-World Patient Access Capability, Advancing CMS-Aligned Network Goals |
| 2026-04-09 | +0.6% | news | Yahoo Finance | DaVita HealthCare (DVA) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance |
| 2026-04-09 | +0.6% | news | bitget.com | Reasons to Keep DaVita Stock in Your Investment Portfolio at This Time - bitget.com |
| 2026-04-09 | +0.6% | analyst | MarketWatch | DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2026-04-09 | +0.6% | news | Eastern Progress | Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Eastern Progress |
| 2026-01-02 | -0.6% | news | TIKR.com | Who Owns DaVita? Top Shareholders and Recent Insider Trades - TIKR.com |
| 2022-02-09 | +0.5% | legal | SEC EDGAR | DVA 8-K: 8.01 and (SEC Filing) |
| 2026-02-23 | +0.4% | news | Yahoo Finance | Is DaVita (DVA) Stock Undervalued Right Now? - Yahoo Finance |
| 2026-02-23 | +0.4% | legal | DirectorsTalk Interviews | DaVita Inc. (DVA) Stock Analysis: Navigating the Healthcare Sector with a Strong Return on Equity - DirectorsTalk Interviews |
| 2025-05-23 | -0.4% | legal | SEC EDGAR | DVA 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-04-10 | -0.3% | news | AD HOC NEWS | DaVita Inc. stock (US23918K1088): Is its dialysis dominance strong enough to unlock new upside? - AD HOC NEWS |
| 2026-01-16 | +0.3% | news | TradingView | DaVita - In the sweet spot of Growth and Value - TradingView |
| 2026-03-09 | -0.2% | news | Seeking Alpha | DaVita tops chart as the only large-cap healthcare services name rated Strong Buy |
| 2026-03-09 | -0.2% | news | Seeking Alpha | DaVita tops chart as the only large-cap healthcare services name rated Strong Buy (DVA:NYSE) - Seeking Alpha |
| 2025-11-01 | -0.2% | earnings | Seeking Alpha | Earnings Scorecard: 24 out of 25 healthcare firms deliver EPS wins this week |
| 2025-07-17 | +0.1% | legal | SEC EDGAR | DVA 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-04-11 | +0.0% | analyst | Seeking Alpha | DaVita: Further Upside Is Trickier (Rating Downgrade) |
| 2026-04-11 | +0.0% | earnings | MarketBeat | Aberdeen Group plc Has $230,000 Stake in DaVita Inc. $DVA - MarketBeat |
| 2026-04-11 | +0.0% | analyst | Seeking Alpha | DaVita - Further Upside Is Trickier (Rating Downgrade) (NYSE:DVA) - Seeking Alpha |
| 2025-11-13 | +0.0% | legal | Seeking Alpha | Short bets on S&P 500 Healthcare sector rises to 2.00% in October; MRNA stays most shorted stock |
| 2025-11-13 | +0.0% | earnings | Yahoo Finance | Unpacking Q3 Earnings: DaVita (NYSE:DVA) In The Context Of Other Outpatient & Specialty Care Stocks - Yahoo Finance |
| 2026-04-26 | — | news | MSN | Here's why you should retain DaVita stock in your portfolio for now - MSN |
| 2026-04-25 | — | earnings | MarketBeat | DaVita Inc. $DVA Stock Position Decreased by Mirae Asset Global Investments Co. Ltd. - MarketBeat |
| 2026-04-24 | — | news | ChartMill | DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill |
| 2026-04-24 | — | news | MarketWatch | DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch |